CARDINAL HEALTHCARE: Drug Recall
Recall #D-0190-2024 · 01/26/2022
Class II: Risk
Recall Details
- Recall Number
- D-0190-2024
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- CARDINAL HEALTHCARE
- Status
- Terminated
- Date Initiated
- 01/26/2022
- Location
- Dublin, OH, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1 unit
Reason for Recall
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Product Description
Meloxicam Tablets, USP, 15 mg, 1000 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., Kurkumbh, India; Manufactured for: Cipla USA, Inc., 9100 S. Dadeland Blvd., Suite 1500 Miami, FL 33156. NDC: 69097-159-15
Distribution Pattern
Nationwide USA
Other Recalls by CARDINAL HEALTHCARE
- Class II: Risk 01/26/2022
- Class II: Risk 01/26/2022
- Class II: Risk 01/26/2022
- Class II: Risk 01/26/2022
- Class II: Risk 01/26/2022
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.